http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006021644-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6c52495e8443494c5c2e1133477ec2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fdae843ef35e7a4d48164599b78cc28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c793cfebe29c0f806cfa048af9f1ccc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ca56651542e09c0636e11ac8a6b478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_970760343fa189fb6d712072d56d9a99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bce8e32ba4907f11591ff3d339c4fee8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20
filingDate 2005-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_666a195743e45413d3b4a40115635c68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8325639c12abf388909a369af1bd60c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70d8210f5275dc48f60f05c7c126075e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b309c3369ca907fd25d48b68e8adcb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6911e59e177e2d1fb22c3e0bea11b649
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601d5e246f3295f6ac956f1bcea76d3e
publicationDate 2006-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006021644-A1
titleOfInvention Water-soluble crosslinked hyaluronic acid, a method for the preparation thereof, implant containing said crosslinked hyaluronic acid and the use thereof
abstract The invention relates to a crosslinked hyaluronic acid exhibiting a water-solubility and obtainable by a preparation method consisting in bringing into contact at least one type of hyaluronic acid or the salts thereof and at least one type of cross-linking agent containing at least one type of oligopeptide or polypeptide having at least two, preferably at least five lysine units, in an aqueous medium, wherein said contact operation is carried out in the presence of at least one type of hydrosoluble coupling agent and at least one catalyst. An implant containing the inventive crosslinked hyaluronic acid and the use thereof for human medicine and veterinary science, in particular for repair or aesthetic surgery is also disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010509425-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2489374-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101611063-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108379112-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10434214-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114026157-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111246919-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008056069-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2501943-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101478849-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111246919-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10905797-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10994049-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11154484-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111732741-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2007316520-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000626-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11083684-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008068297-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11732093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101594892-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10806821-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019020344-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10722444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2908415-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2501943-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2909560-A1
priorityDate 2004-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003036518-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1535952-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004004744-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6630457-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001039336-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127800576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226573460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID52999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID181649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53784172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129066082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127961291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20355182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID138203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226436208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129515268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127880235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127399564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7220

Total number of triples: 81.